Chartwell Investment Partners, LLC Exact Sciences Corp Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 09, 2018
SELL
$37.84 - $69.96 $1.2 Million - $2.21 Million
-31,594 Closed
0 $0
Q4 2017

Feb 08, 2018
SELL
$46.49 - $60.51 $974,662 - $1.27 Million
-20,965 Reduced 39.89%
31,594 $1.66 Million
Q3 2017

Nov 08, 2017
BUY
$37.05 - $47.12 $1.95 Million - $2.48 Million
52,559
52,559 $2.48 Million

Others Institutions Holding EXAS

# of Institutions
641
Shares Held
155M
Call Options Held
1.74M
Put Options Held
1.54M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.94B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email